Current and upcoming radionuclide therapies in the direction of precision oncology: A narrative review
As new molecular tracers are identified to target specific receptors, tissue, and tumor types, opportunities arise for the development of both diagnostic tracers and their therapeutic counterparts, termed “theranostics.” While diagnostic tracers utilize positron emitters or gamma-emitting radionucli...
Main Authors: | Hina J. Shah, Evan Ruppell, Rozan Bokhari, Parag Aland, Vikram R. Lele, Connie Ge, Lacey J. McIntosh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | European Journal of Radiology Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352047723000035 |
Similar Items
-
Theranosticsin nuclear medicine and oncology
by: Sergio Baldari, et al.
Published: (2019-04-01) -
7Be and 22Na radionuclides for a new therapy for cancer
by: Kukulin Vladimir I., et al.
Published: (2023-12-01) -
Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy
by: Sofia Koustoulidou, et al.
Published: (2021-03-01) -
Radionuclide teranostic of malignancies
by: V. I. Chernov, et al.
Published: (2016-11-01) -
The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
by: Holis Abdul Holik, et al.
Published: (2022-05-01)